BLB&B Advisors Portfolio holdings
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$11M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$7.52M |
| 3 |
Schwab US Mid-Cap ETF
SCHM
|
+$6.08M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6M |
| 5 |
Vanguard Growth ETF
VUG
|
+$5.72M |
Top Sells
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.76M |
| 2 |
ConocoPhillips
COP
|
+$1.67M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$980K |
| 4 |
Corning
GLW
|
+$926K |
| 5 |
Qualcomm
QCOM
|
+$874K |
Sector Composition
| 1 | Technology | 12.37% |
| 2 | Healthcare | 9.55% |
| 3 | Financials | 7.04% |
| 4 | Consumer Staples | 5.54% |
| 5 | Industrials | 4.89% |
Similar funds
BLB&B Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, BLB&B Advisors held 276 positions worth $1.23B, up 24% from $995M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
BLB&B Advisors deployed $111M of net new capital in Q4 2020, opening 34 new positions and adding to 121 existing holdings. Its largest new stake was Schwab US Large-Cap Growth ETF: 104,304 shares worth $1.67M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.76M trimmed.
- BLB&B Advisors's largest Q4 2020 buy was Schwab US Large-Cap Growth ETF: 104,304 shares worth $1.67M.
- BLB&B Advisors added most to Vanguard FTSE Developed Markets ETF in Q4 2020, an estimated $11M increase.
- BLB&B Advisors's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.76M.
- BLB&B Advisors fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $513K.
- BLB&B Advisors's ten largest holdings make up 37% of its $1.23B portfolio in Q4 2020.
- BLB&B Advisors opened 34 new positions and closed 10 in Q4 2020.
- BLB&B Advisors's portfolio value rose 24% quarter-over-quarter to $1.23B.
Based on BLB&B Advisors's 13F filing for Q4 2020, filed 19 Jan 2021.